26th Annual ESGO 2025 Congress
Discover it Now!
The Prevention Committee was established in 2019 to fulfil the ESGO vision: Best treatment and prevention in gynaecological cancer. ESGO has set as its mission to improve the health and well-being of women with gynaecological cancers through prevention, research, excellence in care and education. The Prevention Committee is therefore one of the cornerstones to ensure the fulfilment of its mission.
The Chair of the Prevention Committee is Prof. Murat Gultekin.
Prevention Committee Chair: Murat Gultekin
Prevention Executive Group:
Marc Arbyn, Nicolo Bizzarri, Kimon Chatzistamatiou, Mihaela Grigore, Reda Hemida, Elmar Joura, Vesna Kesic, Maria Kyrgiou, Claudia Marchetti, Mario Preti
Core Group (Council members): Frederic Amant, Daniela Fisherova, Zoltan Novak, Jalid Sehouli
Members:
Utku Akgor, Esat Bilal, Sarah Bowden, Laia Bruni, Laura Burney Ellis, Murat Cengiz, Volkan Ege, Dimitrios Haidopulos, Houssein El Hajj, Nicolo Gallio, Omar Gassama, Livia Giordano, Charlotte Goutallier, Joana Kacperczyk-Bartnik, Belen Lopez, Edina Lukacs, Anita Mitra, Nagham Ibraheem Mahdi, Afraa Mahjoob Al-Naddawi, Gadelkareem Nassar, Eva-Maria Niine-Roolaht, Patrick Petignat, Alejandra Picconi, Zoia Razumova, Jalid Sehouli, Aleksandra Shavrova, Nadja Taumberger, Charalampos Theofanakis, Icó Tóth, Andreas Ullrich, Zvi Vaknin, Alexandra Wagner, Ignacio Zapardiel
Please register for this webinar here.
+ Risk factors for endometrial carcinoma (Beyhan Ataseven)
+ Medical prevention (Claudia Marchetti)
+ Surgical prevention (Dimitrios Haidopulos)
Moderators: Murat Gultekin, Laura B. Ellis
All Prevention Committee webinars are available on the eAcademy portal
Click on the link to see them all.
For recordings go to the ESGO eAcademy portal. You need to register to access it.
For recordings go to ESGO eAcademy portal. You need to register to access.
For recordings please go to the ENGAGe YouTube channel.
treatment for cervical intra-epithelial neoplasia and early invasive cervical cancer, M. Kyrgiou Accepted for publication in Lancet Oncology.
vulvar and vaginal disease, M. Preti (Accepted as joint publication in IJGC and LJGTD).
World Health Organization has launched ''Cervical Cancer Elimination Program'' on November 19, 2020.
The program asks the countries to vaccinate the girls under 15 years of age (90% coverage), to screen females by minimal two times when they are 35 and 45 (70%) coverage and to treat the lesions detected appropriately (in 90% of cases).
Modelling studies show that if all countries can implement the program until 2030 and can achieve these targets, there will be a 30% reduction in cervical cancer mortality by 2030 and the cervical cancer may be eliminated until the end of this century (namely incidence less than 4 \ 100.000).
ESGO Prevention committee has joined in to fulfil the WHO cervical cancer elimination strategy as a leading European actor in prevention.
RISCC: Risk-based Screening for Cervical Cancer
ESGO/ENGAGe is involved in the Horizon 2020 RISCC project.
Within the RISCC project ESGO / ENGAGe is responsible for the co-creation of the e-health/m-health platform for risk based cervical cancer screening and for the dissemination of the results to 12 ENGAGe member countries. This project is planned for five years and intended to terminate in 2025.
For more information about the ESGO/ENGAGe involvement please use the following link.